The case of a 12-year-old boy with neurofibromatosis, kyphoscoliosis, and hypertension is reported. The association of neuroflibromatosis and kryphoscoliosis is well known. There are no reports on the association of neurofibromatosis and hypertension in the orthopaedic literature. The cause was found to be intrarenal vascular abnormalities which are characteristic of neurofibromatosis. Other possible causes of hypertension in this disease are discussed. This patient was successfully treated by a partial nephrectomy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007632-197905000-00008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation.
J Clin Med
December 2024
Département de Neurochirurgie, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
: Vestibular schwannomas (VSs), also called acoustic neuromas, are benign tumors affecting the vestibulocochlear nerve, often leading to hearing loss and balance issues. This condition is particularly challenging in patients with neurofibromatosis type 2 (NF2), where VSs tend to develop bilaterally. Conventional treatments, such as surgery and radiotherapy, although effective, carry risks like hearing loss and nerve damage.
View Article and Find Full Text PDFEndovascular salvage of renal artery bypass in pediatric a patient with neurofibromatosis type 1.
J Vasc Surg Cases Innov Tech
February 2025
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Neurofibromatosis type 1 (NF1) is a congenital vasculopathy that can affect the renal arteries, causing renovascular hypertension. We report a complex case of a pediatric NF1 patient who required endovascular salvage of a renal artery bypass. Treatment for pediatric renovascular NF1 requires close surveillance and the ability to pivot to rescue therapies.
View Article and Find Full Text PDFGenotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study.
Hum Genome Var
November 2024
Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Neurofibromatosis type 1 (NF1) presents with a broad spectrum of clinical manifestations, including an increased risk of tumor development and hypertension. Comprehensive data on genotype‒phenotype correlations in patients with NF1 are limited. Therefore, in this study, we aimed to elucidate the detailed genetic and clinical characteristics of NF1 in a hereditary tumor cohort.
View Article and Find Full Text PDFNeurofibromatosis Type 1 Patients With Epilepsy: A Comprehensive Analysis of Demographics, Comorbidities and Healthcare Outcomes.
Exp Dermatol
November 2024
Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Article Synopsis
- * Epilepsy occurs in about 4%-7% of NF1 patients, with limited research exploring its connections to NF1 demographics and health outcomes.
- * A study analyzing 4,635 NF1 patients found that those with epilepsy were primarily White males from lower-income backgrounds and identified several health issues that increase the likelihood of epilepsy in NF1 patients, leading to shorter hospital stays and fewer procedures.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!